AI & Tech
Regulators Start Writing the Rules for AI-Driven Medicines
The joint FDA-EMA principles for AI in drug development show regulators trying to align before AI becomes embedded across discovery, trials, manufacturing and post-market safety.
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.